Last reviewed · How we verify

NCT05821816

Effect of Transcranial Direct Current Stimulation (tDCS) on Post-stroke Patients on Neuromotor Recovery

Completed NA Last updated 13 March 2025
What this trial tests

NA trial testing tDCS in Stroke in 50 participants. Completed in 1 February 2025.

Timeline
2 March 2023
Primary endpoint
1 February 2025
1 February 2025

Quick facts

Lead sponsorI.R.C.C.S. Fondazione Santa Lucia
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment50
Start date2 March 2023
Primary completion1 February 2025
Estimated completion1 February 2025
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

I.R.C.C.S. Fondazione Santa Lucia — full company profile →

Who can join

Adults 18 to 100, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to evaluate whether a non-invasive brain stimulation technique (Transcranial Direct Current Stimulation) can influence the secondary neurodegeneration observed after a stroke (assessed based on serum concentration of neurofilaments) and can improve the functional outcome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of tDCS

Trials testing the same drug.

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other I.R.C.C.S. Fondazione Santa Lucia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05821816.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing